OPIS is a Global Full-Service clinical CRO providing premium clinical trial management for multi-country trials. In addition, to phase I-IV drug-related trials, OPIS also manages pre-and post-marketing clinical investigations for medical/diagnostic devices and nutraceutical/food supplement studies. Founded in 1998, the company counts 14 offices around the world (Italy, Spain, France, Germany, UK, Belgium, Sweden, Poland, Switzerland, Netherlands, Taiwan, Australia, Korea, and the US).